Overview

A Study to Evaluate Androderm's Effect on Blood Pressure in Adult Hypogonodal Male Participants.

Status:
Completed
Trial end date:
2021-06-24
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of a once daily Androderm dose on Blood Pressure (BP) in adult hypogonadal men as measured by 24-hour ABPM
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate